Western blotting is a technique that is specifically used for protein analysis. The western blotting technique initiates with separation of molecules using gel electrophoresis. At the end of electrophoresis the separated molecules are transferred to a second matrix which commonly includes polyvinylidene difluoride (PVDF) or nitrocellulose membrane. Then, to prevent any nonspecific binding of antibodies to the surface of the membrane it is blocked with a specific mechanism. As a probe was combined with an enzyme-labeled antibody an appropriate substrate is then added to the enzyme which together produces detectable product such as chromogenic precipitate on the membrane for colorimetric detection. There are two types of western blotting procedures direct and in direct detection methods. The various advantages associate with direct method are rapid effect due to presence of one antibody, and primary antibodies. The disadvantages of direct detection method consist of reduced immunoreactivity of primary antibody labeled primary antibody, expensive, low flexibility in choice of primary antibody label and minimal signal amplification. Moreover, indirect detection method has advantages such as secondary antibody amplifying signal, variety of labeled secondary antibodies, and primary antibody immunoreactivity remain unaffected by labeling. The various disorders related with indirect detection are non-specific staining produced by secondary antibodies and a time consuming process due to presence of additional steps.
The western blotting market can be segmented on the basis of type of instrument such as manual, semi-automated and automated instruments. The consumables that are used in western blotting are also part of this market; western blotting kits, western blotting reagents and others. The western blotting reagents can be further sub-segmented as fluorescent reagents, chemifluorescent reagents, radioisotopic, reagents, chemiluminescent reagents, and chromogenic reagents. The other western blotting consumables are western blotting membranes, blotting papers and molecular weight markers. The western blotting market can be also segmented on the basis of its applications such as biomedical research, agriculture, disease diagnosis, and biochemical research. The diseases that are mainly diagnosed with the help of western blotting technique are human immunodeficiency virus (HIV), LYME disease, bovine spongiform encephalopathy (BSE), feline immunodeficiency virus (FIV), Hepatitis B virus (HBV) and herpes simplex virus (HSV).
North America was observed to be the largest market for western blotting market. High awareness, escalating prevalence of diseases and introduction of advanced diagnostic technologies are the major factors driving the growth of this market. In 2010, according to Centers for Disease Control and Prevention (CDC), an estimated 1,148,200 persons aged 13 years and above were diagnosed with HIV infection in the United States, including 207,600 (18.1%) persons whose infections had not been diagnosed. Europe was observed to be the second largest market and one of the leading research destinations for diagnostics and treatment for BSE and HIV diseases. According to UNAIDS estimates, around 2.3 million people were diagnosed with HIV in the European region at the end of 2010. Estimated adult HIV prevalence varies from 0.2% in parts of Central Europe to 1% in parts of Eastern Europe. Asia-Pacific and Rest of the World were observed to be the most potential markets for western blotting market. These regions are developing their infrastructure and medical emergency processes which increase the demand for disease diagnostics techniques. The future growth in these geographical regions is expected due to increase in the diagnosed patients especially from the emerging economies such as India, Brazil, China, and other countries.
Some of the key players operating in this market are Bio-Rad Laboratories, Inc., Advansta Inc., Proteinsimple, Inc., Li-Cor Biosciences, Sigma-Aldrich Corporation, GE Healthcare, Perkinelmer, Inc., Merck Millipore, Roche Applied Science, Thermo Fisher Scientific, Inc. and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.